Mutated tau protein fragment and use thereof

Abstract

A mutated tau protein fragment and a use thereof are disclosed. The mutated tau protein fragment consists 12 amino acid residues and thus can easily be prepared. In addition, when the mutated tau protein fragment is injected into an individual as an antigen, a neutralizing antibody against the mutated tau protein is generated. Moreover, the mutated tau protein fragment reduces the aggregation of abnormal tau proteins. Accordingly, the mutated tau protein fragment can be effectively used for the prevention or treatment of degenerative neurological diseases.

Dependencies are inferred from the claim text.